Related Experiment Video
Updated: May 14, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Focal adhesion kinase regulates expression of thioredoxin-interacting protein (TXNIP) in cancer cells
Baotran Ho, Grace Huang, Vita M Golubovskaya1
1Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA. Vita.Golubovskaya@roswellpark.org.
Abstract:
Focal Adhesion Kinase (FAK) plays an important role in cancer cell survival. Previous microarray gene profiling study detected inverse regulation between expression of thioredoxin-interacting protein (TXNIP) and FAK, where down-regulation of FAK by siRNA in MCF-7 cells caused up-regulation of TXNIP mRNA level, and in contrast up-regulation of doxycyclin- induced FAK caused repression of TXNIP. In the present report, we show that overexpression of FAK in MCF-7 cells repressed TXNIP promoter activity. Treatment of MCF-7 cells with 1alpha, 25-dihydroxyvitamin D3 (1,25D) down-regulated endogenous FAK and up-regulated TXNIP protein level, and treatment with 5-FU decreased FAK protein expression and up-regulated TXNIP protein expression in 293 cells. Moreover, silencing of FAK with siRNA increased TXNIP protein expression, while overexpression of FAK inhibited TXNIP protein expression in 293 cells. In addition, treatment of DBTRG glioblastoma cells with FAK inhibitor Y15 increased TXNIP mRNA, decreased cancer cell viability and increased apoptosis. These results for the first time demonstrate FAK-regulated TXNIP expression which is important for apoptotic, survival and oxidative stress signaling pathways in cancer cells.
Insights
This study reveals that Focal Adhesion Kinase (FAK) regulates thioredoxin-interacting protein (TXNIP) expression. Inhibiting FAK in cancer cells increases TXNIP, impacting cell survival and apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Focal Adhesion Kinase (FAK) is crucial for cancer cell survival.
- Previous studies indicated an inverse relationship between FAK and thioredoxin-interacting protein (TXNIP) expression.
- Understanding this interaction is key to developing new cancer therapies.
Purpose of the Study:
- To elucidate the regulatory relationship between FAK and TXNIP.
- To investigate the functional consequences of FAK-TXNIP interaction in cancer cells.
- To explore potential therapeutic strategies targeting the FAK-TXNIP axis.
Main Methods:
- Gene expression profiling (microarray).
- Overexpression and silencing of FAK using siRNA and doxycycline-induced systems.
- Reporter assays to assess promoter activity.
- Treatment with 1alpha, 25-dihydroxyvitamin D3 (1,25D), 5-fluorouracil (5-FU), and FAK inhibitor Y15.
- Cell viability and apoptosis assays.
Main Results:
- Overexpression of FAK repressed TXNIP promoter activity in MCF-7 cells.
- 1,25D and 5-FU treatments modulated FAK and TXNIP protein levels.
- FAK silencing increased TXNIP protein expression, while FAK overexpression inhibited it in 293 cells.
- FAK inhibition in glioblastoma cells increased TXNIP mRNA, reduced cell viability, and enhanced apoptosis.
Conclusions:
- FAK directly regulates TXNIP expression.
- The FAK-TXNIP axis plays a significant role in cancer cell apoptosis, survival, and oxidative stress signaling.
- Targeting FAK could be a viable strategy for cancer treatment by modulating TXNIP.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
lncRNA - Long Non-coding RNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
